PCVX

Vaxcyte (PCVX) Stock Analysis

Research Vaxcyte (PCVX) with company financials, earnings context, valuation indicators, risk analysis and related market news.

Research record updated: . Individual measures may refer to different reporting periods.

Ticker
PCVX
Company
Vaxcyte
Sector
Healthcare
Industry
Biotechnology
Market cap
$9.93B
Financial data source
Yahoo Finance + FMP cash flow statements + FMP balance sheet + income statements + StockAnalysis complete statements
Annual revenue (reporting year not supplied)
$0.00
Annual net income (reporting year not supplied)
$-766.63M
Annual free cash flow (reporting year not supplied)
$-669.29M
Trailing revenue
$0.00
Trailing net income
$-1.06B
Total assets
$3.00B
Total liabilities
$317.21M

Vaxcyte (PCVX) Stock Analysis research

Review the available company profile, financial history, valuation context and investor signals for Vaxcyte. Compare the reported operating results with the valuation and risk measures below.

The figures are cached research data and can change after new filings, earnings reports or market updates. Verify material facts with primary company disclosures before making an investment decision.